Role of Hepcidin on Response of Erythropoietin Stimulating Agents in Anaemic Advanced Chronic Kidney Disease Patients

Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 10

Abstract

ABSTRACT Introduction: Anaemia contributes significantly to the morbidity and mortality in Chronic Kidney Diseases (CKD). Erythropoietin Stimulating Agents (ESA) have revolutionised the management of the anaemia in CKD patients. However, over 50% of the patients do not reach the target haemoglobin level. Hepcidin which plays important role in iron metabolism and inflammation may be the cause of this hyporesponsiveness to ESA. Aim: The present study was aimed to assess possible relation between hepcidin and erythropoietin therapy with special attention to hyporesponsive anaemia in advanced kidney disease. Materials and Methods: In this cross sectional study, total of 81 clinically stable patients from Department of Medicine and Nephrology, King George’s Medical University, Lucknow of advanced CKD on ESA for past 12 weeks were enrolled. Patients whose haemoglobin rose more than 2 gm/dL or were above 10 gm/dL were classified as responders while below 10 gm/dL were classified as poor responders. Results: In present study, majority 54 patients (66.7%) were poor responders to ESA. We found significant higher level of hepcidin in poor responders (p=0.01) while no significant variation in serum iron, Transferrin Saturation (TSAT) and ferritin. High sensitivity C-Reactive Protein (hsCRP) was markedly elevated with median value 3.13 mg/L and Interquartile Range (IQR) (1.14-13.78) in all patients. Conclusion: Hepcidin may be one of the causes of hyporesponsiveness to ESA due to reticulo-endothelial blockade of iron.

Authors and Affiliations

Satyendra Kumar Sonkar, Anil Kumar, Neeraj Kumar Singh, Gyanendra Kumar Sonkar, Sant Pandey, Vivek Bhosale

Keywords

Related Articles

To Determine Tooth Discolouration After Treatment with Various Endodontic Materials using Spectrophotometric Analysis-An In-Vitro Study

ABSTRACT Introduction: Various materials have been tried to minimise tooth discolouration over the years. Calcium silicate-based cements have been available for many years. These biomaterials have been used in various en...

Takayasu’s Arteritis and Systemic Lupus Erythematosus-A Rare Coexistence

ABSTRACT Takayasu arteritis, also known as “pulseless disease” is an inflammatory disease characterized by large caliber artery inflammation. Although tuberculosis and syphilis are known to be associated with Takayasu ar...

Duodenal Biopsy in the Evaluation of Chronic Diarrhoea in Immunosuppressed Patients from a Tertiary Care Center in Southern India

ABSTRACT Introduction: Chronic diarrhoea in immunocompromised patients is due to a variety of causes including opportunistic pathogens that flourish in such a milieu. While stool examination may diagnose some pathogens,...

Is Obesity a Concern in Breast Cancer?

ABSTRACT Introduction: Breast cancer is one of the commonest cancers in women in India. The risk factors also include modifiable ones such as obesity. Obesity has been shown to increase the risk of developing breast canc...

The Impact of Three-month Training Programme on Foot Care and Self-efficacy of Patients with Diabetic Foot Ulcers

Introduction: Patient’s self-efficacy in disease management and foot care is considered as an important indicator in controlling the complications of diabetes. Aim: This study was aimed to determine the effect of threemo...

Download PDF file
  • EP ID EP526692
  • DOI 10.7860/JCDR/2018/36051.12142
  • Views 58
  • Downloads 0

How To Cite

Satyendra Kumar Sonkar, Anil Kumar, Neeraj Kumar Singh, Gyanendra Kumar Sonkar, Sant Pandey, Vivek Bhosale (2018). Role of Hepcidin on Response of Erythropoietin Stimulating Agents in Anaemic Advanced Chronic Kidney Disease Patients. Journal of Clinical and Diagnostic Research, 12(10), 14-16. https://europub.co.uk/articles/-A-526692